DLBCL

News

12/15/2020

In a study of patients with relapsed/refractory B-Cell NHL, the ViPOR regimen led to complete responses, with no unexpected toxicities.

In a study of patients with...

12/15/2020

Oncology

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19